Find out about the exciting progress being made with gamma secretase modulators, a potential drug therapy for Alzheimer’s, in this one-hour webinar. Steven Wagner, Ph.D., principal investigator at UC San Diego’s Department of Neuroscience, talks to David Shenk, senior adviser, Cure Alzheimer’s Fund, about how the modulators work and what’s being done to get them to human trials. This webinar was recorded at our annual Research Consortium meeting in San Diego.